Development and Encapsulation of Affibody-Apoferritin Biologics for the Targeted Treatment of Breast Cancer
Targeted cancer therapies produce more favourable clinical outcomes for cancer patients compared to unselective small-molecule cytotoxic chemotherapeutics. Currently, the most widely available targeted anti-cancer therapies are antibody-drug conjugates (ADC) with an example being tratuzumab-DM1 (Kad...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/78748/ |